Search
for
Sort by
Research 31–60 of 1000+
- Targeted therapy in melanoma
- The Roles of S100 Proteins and RAGE in Melanoma
- 647 NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing caspase-3 activity in human melanoma
- RAGE and Its Ligands in Melanoma
- The potential impact of melanosomal pH and metabolism on melanoma
- Biological therapy in the treatment of melanoma
- Clinical Case Notes. Malignant melanoma in eviscerated eyeball
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Anti-Melanogenic and Anti-Oxidative Effects of Nostoc verrucosum (ashitsuki) Extracts
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- News in brief
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- Highlights
- 642 Uncovering the role of UV exposure history and genetics in determining skin sun damage
- LOP12
- LOP12
- Tebentafusp-tebn (Kimmtra®)
- Functional analysis of thymosin beta-4 using over-expressing transgenic mice
- LOP14
- LOP14
- Aldesleukin
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Coexistence of a Basal Cell Carcinoma and Leiomyosarcoma
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- LB1602 Skin cancer in skin of color transplant patients
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- CPC12 Coinheritance of <i>BRCA2</i> and <i>CYLD</i> germline pathogenic variants associated with targetable metastatic malignant cylindroma
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation